Álvaro Aparisi

InstitutionHospital Clínico Universitario
AddressValladolid
Spain
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 14 publications over 3 distinct years, with a maximum of 10 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. García-Granja PE, Veras C, Aparisi Á, Amat-Santos IJ, Catalá P, Marcos M, Cabezón G, Candela J, Gil JF, Uribarri A, Revilla A, Carrasco M, Gómez I, San Román JA. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Engl Ed). 2021 Jul 23; 157(2):58-63. PMID: 34307884.
      Citations: 1     
    2. Aparisi Á, Iglesias-Echeverría C, Ybarra-Falcón C, Cusácovich I, Uribarri A, García-Gómez M, Ladrón R, Fuertes R, Candela J, Tobar J, Hinojosa W, Dueñas C, González R, Nogales L, Calvo D, Carrasco-Moraleja M, San Román JA, Amat-Santos IJ, Andaluz-Ojeda D. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr Metab Cardiovasc Dis. 2021 08 26; 31(9):2619-2627. PMID: 34353699.
      Citations: 4     Fields:    Translation:HumansCells
    3. Citations: 1     
    4. Aparisi Á, Catalá P, Amat-Santos IJ, Marcos-Mangas M, López-Otero D, Veras C, López-Pais J, Cabezón-Villalba G, Cacho Antonio CE, Candela J, Antúnez-Muiños P, Gil JF, González Ferrero T, Rojas G, Pérez-Poza M, Uribarri A, Otero-García O, García-Granja PE, Jiménez Ramos V, Revilla A, Dueñas C, Gómez I, González-Juanatey JR, San Román JA. Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis. Med Clin (Barc). 2021 May 06. PMID: 34088524.
      Citations:    Fields:    
    5. Cusacovich I, Aparisi Á, Marcos M, Ybarra-Falcón C, Iglesias-Echevarria C, Lopez-Veloso M, Barraza-Vengoechea J, Dueñas C, Juarros Martínez SA, Rodríguez-Alonso B, Martín-Oterino JÁ, Montero-Baladia M, Moralejo L, Andaluz-Ojeda D, Gonzalez-Fuentes R. Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality. Mediators Inflamm. 2021; 2021:6637227. PMID: 33776574.
      Citations: 2     Fields:    Translation:Humans
    6. Uribarri A, Núñez-Gil IJ, Aparisi Á, Arroyo-Espliguero R, Maroun Eid C, Romero R, Becerra-Muñoz VM, Feltes G, Molina M, García-Aguado M, Cerrato E, Capel-Astrua T, Alfonso-Rodríguez E, Castro-Mejía AF, Raposeiras-Roubín S, Espejo C, Pérez-Solé N, Bardají A, Marín F, Fabregat-Andrés Ó, D'ascenzo F, Santoro F, Akin I, Estrada V, Fernández-Ortiz A, Macaya C. [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. Rev Esp Cardiol. 2021 Jul; 74(7):608-615. PMID: 33678938.
      Citations: 2     Fields:    
    7. Aparisi Á, Amat-Santos IJ, López Otero D, Marcos-Mangas M, González-Juanatey JR, San Román JA. [Impact of statins in patients with COVID-19]. Rev Esp Cardiol. 2021 Jul; 74(7):637-640. PMID: 33654339.
      Citations:    Fields:    
    8. García-Granja PE, Veras C, Aparisi Á, Amat-Santos IJ, Catalá P, Marcos M, Cabezón G, Candela J, Gil JF, Uribarri A, Revilla A, Carrasco M, Gómez I, San Román JA, San Román JA. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Barc). 2021 07 23; 157(2):58-63. PMID: 33637334.
      Citations: 3     Fields:    Translation:Humans
    9. Aparisi Á, Amat-Santos IJ, López Otero D, Marcos-Mangas M, González-Juanatey JR, San Román JA. Impact of statins in patients with COVID-19. Rev Esp Cardiol (Engl Ed). 2021 07; 74(7):637-640. PMID: 33593686.
      Citations: 2     Fields:    Translation:Humans
    10. Uribarri A, Núñez-Gil IJ, Aparisi Á, Arroyo-Espliguero R, Maroun Eid C, Romero R, Becerra-Muñoz VM, Feltes G, Molina M, García-Aguado M, Cerrato E, Capel-Astrua T, Alfonso-Rodríguez E, Castro-Mejía AF, Raposeiras-Roubín S, Espejo C, Pérez-Solé N, Bardají A, Marín F, Fabregat-Andrés Ó, D'ascenzo F, Santoro F, Akin I, Estrada V, Fernández-Ortiz A, Macaya C. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed). 2021 Jul; 74(7):608-615. PMID: 33583755.
      Citations: 1     Fields:    Translation:Humans
    11. Núñez-Gil IJ, Fernández-Pérez C, Estrada V, Becerra-Muñoz VM, El-Battrawy I, Uribarri A, Fernández-Rozas I, Feltes G, Viana-Llamas MC, Trabattoni D, López-País J, Pepe M, Romero R, Castro-Mejía AF, Cerrato E, Astrua TC, D'Ascenzo F, Fabregat-Andres O, Moreu J, Guerra F, Signes-Costa J, Marín F, Buosenso D, Bardají A, Raposeiras-Roubín S, Elola J, Molino Á, Gómez-Doblas JJ, Abumayyaleh M, Aparisi Á, Molina M, Guerri A, Arroyo-Espliguero R, Assanelli E, Mapelli M, García-Acuña JM, Brindicci G, Manzone E, Ortega-Armas ME, Bianco M, Trung CP, Núñez MJ, Castellanos-Lluch C, García-Vázquez E, Cabello-Clotet N, Jamhour-Chelh K, Tellez MJ, Fernández-Ortiz A, Macaya C. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966. PMID: 33165755.
      Citations: 6     Fields:    Translation:Humans
    12. San Román JA, Uribarri A, Amat-Santos IJ, Aparisi Á, Catalá P, González-Juanatey JR. The presence of heart disease worsens prognosis in patients with COVID-19. Rev Esp Cardiol (Engl Ed). 2020 09; 73(9):773-775. PMID: 32622732.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. San Román JA, Uribarri A, Amat-Santos IJ, Aparisi Á, Catalá P, González-Juanatey JR. [The presence of heart disease worsens prognosis in patients with COVID-19]. Rev Esp Cardiol. 2020 Sep; 73(9):773-775. PMID: 32834366.
      Citations: 3     Fields:    
    Aparisi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (43)
    Explore
    _
    Co-Authors (118)
    Explore
    _
    Similar People (60)
    Explore
    _